B-Cell Depletion Therapy May Be Associated With Poor COVID-19 Outcomes, With Humoral Immune Response Impairment And T-Cell Hyperactivation As Primary Immunologic Features, Study Indicates

Infectious Disease Advisor (12/12, Barowski) reports, “B-cell depletion therapy may be associated with poor COVID-19 outcomes, with humoral immune response impairment and T-cell hyperactivation as the primary immunologic features,” according to a recent study. The findings were published in Infectious Diseases.